Problem statement: Answer the MCQ question.
Query: Which compound exhibits a -19.982% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: Cc1csc(NC(=O)c2ccc3nc[nH]c3c2)n1
b: COc1cc(-c2[nH]ncc2CN(C)Cc2cc(C)[nH]n2)cc(OC)c1OC
c: Cc1cc(C)c2ccc(=S)[nH]c2n1
Answer: a. Cc1csc(NC(=O)c2ccc3nc[nH]c3c2)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1csc(NC(=O)c2ccc3nc[nH]c3c2)n1
Cc1csc(NC(=O)c2ccc3nc[nH]c3c2)n1
N-(4-methyl-1,3-thiazol-2-yl)-3H-benzimidazole-5-carboxamide